- Cuénod A, Wüthrich D, Seth-Smith H, Ott C, Gehringer C, Foucault F, et al. Whole-genome sequence-informed MALDI-TOF MS diagnostics reveal importance of Klebsiella oxytoca group in invasive infections: a retrospective clinical study. Genome Med. 2021;13(1):1-16.
- Marshall JH, Skedros JG, Campana CF, Seibert AM. Diffuse-Type Tenosynovial Giant Cell Tumor of the Knee with Concurrent Polymicrobial Infection (Klebsiella oxytoca and Group B Streptococcus). Case Reports in Infectious Diseases. 2021;2021.
- Hayder T, Aljanaby A. Genotypic Characterization of Antimicrobial Resistance-Associated Genes in Citrobacter Freundii Isolated from Patients with Urinary Tract Infection in Al-Najaf Governorate-Iraq. Online J Biol Sci. 2019;19(2):132-45.
- Osbelt L, Wende M, Almási É, Derksen E, Muthukumarasamy U, Lesker TR, et al. Klebsiella oxytoca causes colonization resistance against multidrug-resistant K. pneumoniae in the gut via cooperative carbohydrate competition. Cell Host Microbe. 2021.
- Tsuka T, Ozaki H, Saito D, Murase T, Okamoto Y, Azuma K, et al. Genetic Characterization of CTX-M-2-Producing Klebsiella pneumoniae and Klebsiella oxytoca Associated With Bovine Mastitis in Japan. Front Vet Sci. 2021;8:412.
- Kadhum HA, Hasan TH. The study of bacillus subtils antimicrobial activity on some of the pathological isolates. Int J Drug Deliv Technol. 2019;9(02):193-6.
- Hasan TH, Al-Harmoosh RA. Mechanisms of antibiotics resistance in bacteria. Sys Rev Pharm. 2020;11(6):817-23.
- Hasan T, Al-Harmoosh R, Al-Khilkhali H. Identification of HIV virus in najaf city, Iraq. Int J Pharm Sci Res. 2020;11(3):4866-71.
- ABUSAIBA THH. Prevalence of hepatitis virus B and C in patients in Al Najaf Governorate, Iraq. Int J Pharm Res. 2020;12(3):1297-303.
- Ortiz de la Rosa JM, Demord A, Poirel L, Greub G, Blanc D, Nordmann P. False immunological detection of CTX-M enzymes in Klebsiella oxytoca. J Clin Microbiol. 2021;59(6):e00609-21.
- Leitner E, Bozic M, Kienesberger S, Cosic A, Landt O, Högenauer C, et al. Improved diagnosis of antibiotic-associated haemorrhagic colitis (AAHC) in faecal specimens by a new qualitative real-time PCR assay detecting relevant toxin genes of Klebsiella oxytoca sensu lato. Clin Microbiol Infect. 2021.
- AL-Khikani FHO, Abadi RM, Ayit AS. Emerging carbapenemase Klebsiella oxytoca with multidrug resistance implicated in urinary tract infection. Biomed Biotechnol Res J. 2020;4(2):148.
- Shukla SD, Muller HK, Latham R, Sohal SS, Walters EH. Platelet‐activating factor receptor (PAFr) is upregulated in small airways and alveoli of smokers and COPD patients. Respirology. 2016;21(3):504-10.
- Neog N, Phukan U, Puzari M, Sharma M, Chetia P. Klebsiella oxytoca and Emerging Nosocomial Infections. Curr Microbiol. 2021:1-9.
- Ghafourian S, Sekawi Z, Neela V, Khosravi A, Rahbar M, Sadeghifard N. Incidence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in patients with urinary tract infection. Sao Paulo Med J. 2012;130:37-43.
- Carrie C, Walewski V, Levy C, Alexandre C, Baleine J, Charreton C, et al. Klebsiella pneumoniae and Klebsiella oxytoca meningitis in infants. Epidemiological and clinical features. Arch Pediatr. 2019;26(1):12-5.
- Lin R-D, Hsueh P-R, Chang S-C, Chen Y-C, Hsieh W-C, Luh K-T. Bacteremia due to Klebsiella oxytoca: clinical features of patients and antimicrobial susceptibilities of the isolates. Arch Clin Infect Dis. 1997;24(6):1217-22.
- Aminzadeh Z, Sadat Kashi M, Sha'bani M. Bacteriuria by extended-spectrum Beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: isolates in a governmental hospital in South of Tehran, Iran. Iranian journal of kidney diseases. 2008;2(4):197-200.
- Livermore DM, Brown DF. Detection of β-lactamase-mediated resistance. J Antimicrob Chemother. 2001;48:59-64.
- Chayakulkeeree M, Junsriwong P, Keerasuntonpong A, Tribuddharat C, Thamlikitkul V. Epidemiology of extended-spectrum beta-lactamase producing gram-negative bacilli at Siriraj Hospital, Thailand, 2003. Southeast Asian J Trop Med. 2005;36(6):1503.
- Bleich A, Kirsch P, Sahly H, Fahey J, Smoczek A, Hedrich H-J, et al. Klebsiella oxytoca: opportunistic infections in laboratory rodents. Lab Anim. 2008;42(3):369-75.
- Razzaque S. A cross sectional study highlighting the sensitivity patterns and incidence of extended spectrum beta lactamase producing Klebsiella oxytoca in patients with urinary tract infection. Int J Pulmonol Infect Dis. 2017;1:1-5.
23. Pérez-Vazquez M, Oteo-Iglesias J, Sola-Campoy PJ, Carrizo-Manzoni H, Bautista V, Lara N, et al. Characterization of carbapenemase-producing Klebsiella oxytoca in Spain, 2016–2017. Antimicrob Agents Chemother. 2019;63(6):02529-18.
|